SEC Form 4 · accession 0000874015-18-000101
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H Wender
Director
Period of report
Jul 17, 2018
Accepted (ET)
Jul 19, 2018 · 6:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 17, 2018 | M | 15,000 | $9.22 | A | 53,916 | I | By Joseph H Wender Trust |
| Common StockF1 | Jul 17, 2018 | M | 15,000 | $9.30 | A | 68,916 | I | By Joseph H Wender Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Director Stock Option (right to buy) | $9.22 | Jul 17, 2018 | M | 15,000 | D | Jul 1, 2014 | Jun 30, 2022 | Common Stock | 15,000 | 0 | D |
| Non-Employee Director Stock Option (right to buy) | $9.30 | Jul 17, 2018 | M | 15,000 | D | Jul 1, 2015 | Jun 30, 2021 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option.